AbstractThe number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each year continues to increase. Advances in HLA typing, better supportive care, and administration of reduced-intensity conditioning regimens allow treatment of older patients with older sibling donors. Pretransplant donor assessment and testing are very important processes affecting the quality and safety of donation. For unrelated HSC donors detailed recommendations for health assessment have been published, allowing donation only if they are unrestrictedly healthy. Eligibility criteria for related donors are less strict and vary significantly between centers. In situations where a family donor does not meet the suitability criteria for unrelate...
Prior to 1979, bone marrow transplants were only performed with histocompatible sibling donors. Once...
Allogeneic Hematopoietic Stem Cell Transplantation is applied in the management of cancer. It involv...
For blood cancer patients, haematopoietic stem cells (HSC) donated by a relative can be lifesaving. ...
The number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each year cont...
AbstractThe number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each y...
The contribution of related donors to the globally rising number of allogeneic haematopoietic stem c...
AbstractRelated donors for hematopoietic cell (HC) transplantation are a growing population in recen...
Allogenic hematopoietic progenitor cell transplantation (allo-HSCT) is an established treatment for ...
HLA matching is the dominant controllable donor-recipient factor determining the outcome of adult un...
The first international recommendations and guidelines for the care of sibling stem cell donors were...
Allogeneic hematopoietic cell transplantation involves consideration of both donor and recipient cha...
Hematopoietic stem cell transplantation (HSCT) is the therapy of choice in many hematological malign...
AbstractTwo parallel phase II trials in adults with hematologic malignancies demonstrated comparable...
peer reviewedHaploidentical hematopoietic stem cell transplantation has been growing steadily since ...
AbstractWorldwide >10 million adults and 250 000 cord blood units are available for unrelated HCT. H...
Prior to 1979, bone marrow transplants were only performed with histocompatible sibling donors. Once...
Allogeneic Hematopoietic Stem Cell Transplantation is applied in the management of cancer. It involv...
For blood cancer patients, haematopoietic stem cells (HSC) donated by a relative can be lifesaving. ...
The number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each year cont...
AbstractThe number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each y...
The contribution of related donors to the globally rising number of allogeneic haematopoietic stem c...
AbstractRelated donors for hematopoietic cell (HC) transplantation are a growing population in recen...
Allogenic hematopoietic progenitor cell transplantation (allo-HSCT) is an established treatment for ...
HLA matching is the dominant controllable donor-recipient factor determining the outcome of adult un...
The first international recommendations and guidelines for the care of sibling stem cell donors were...
Allogeneic hematopoietic cell transplantation involves consideration of both donor and recipient cha...
Hematopoietic stem cell transplantation (HSCT) is the therapy of choice in many hematological malign...
AbstractTwo parallel phase II trials in adults with hematologic malignancies demonstrated comparable...
peer reviewedHaploidentical hematopoietic stem cell transplantation has been growing steadily since ...
AbstractWorldwide >10 million adults and 250 000 cord blood units are available for unrelated HCT. H...
Prior to 1979, bone marrow transplants were only performed with histocompatible sibling donors. Once...
Allogeneic Hematopoietic Stem Cell Transplantation is applied in the management of cancer. It involv...
For blood cancer patients, haematopoietic stem cells (HSC) donated by a relative can be lifesaving. ...